The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study

BACKGROUND AND AIMS: Low-dose naltrexone [LDN] is a controversial off-label treatment used by many Crohn’s disease [CD] and ulcerative colitis [UC] patients. A small number of preliminary studies indicate that LDN might be beneficial in CD, but evidence is too scarce to demonstrate efficacy. We soug...

Descripción completa

Detalles Bibliográficos
Autores principales: Raknes, Guttorm, Simonsen, Pia, Småbrekke, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972567/
https://www.ncbi.nlm.nih.gov/pubmed/29385430
http://dx.doi.org/10.1093/ecco-jcc/jjy008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972567/
https://www.ncbi.nlm.nih.gov/pubmed/29385430
http://dx.doi.org/10.1093/ecco-jcc/jjy008

Ejemplares similares